Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Gainers
- Altimmune, Inc. (NASDAQ:ALT) rose 36.3 percent to $3.94 in pre-market trading after reporting 'positive' results from NasoVAX extension study'.
- StoneCo Ltd. (NASDAQ:STNE) shares rose 21.4 percent to $42.00 in pre-market trading after the company reported higher-than-expected Q4 EPS and sales results.
- Liquid Media Group Ltd. (NASDAQ:YVR) rose 16 percent to $4.00 in pre-market trading after surging 17.35 percent on Monday.
- Vascular Biogenics Ltd. (NASDAQ:VBLT) rose 14.1 percent to $1.95 in pre-market trading after highlighting presentation of new data on potential of VB-111 to stimulate the immune system and drive immune cells to infiltrate tumor microenvironment.
- Affimed N.V. (NASDAQ:AFMD) rose 13.3 percent to $4.44 in pre-market trading after announcing a milestone payment from Genentech.
- Innovate Biopharmaceuticals, Inc. (NASDAQ:INNT) rose 12.1 percent to $2.78 in pre-market trading after climbing 14.9439 percent on Monday.
- Syneos Health, Inc. (NASDAQ:SYNH) rose 9.7 percent to $52.00 in pre-market trading after the company reported higher-than-expected Q4 EPS results. The company also issued FY19 EPS guidance on the high-end of analyst estimates..
- HEXO Corp. (NYSE:HEXO) rose 9.2 percent to $7.35 in pre-market trading after gaining 10.15 percent on Monday.
- Sibanye Gold Limited (NYSE:SBGL) rose 7.8 percent to $4.42 in pre-market trading.
- Michaels Companies Inc (NASDAQ:MIK) rose 6 percent to $12.49 in pre-market trading after reporting better-than-expected results for its fourth quarter.
- Seadrill Limited (NYSE:SDRL) rose 5.7 percent to $9.65 in pre-market trading.
- Amyris Inc (NASDAQ:AMRS) rose 5.5 percent to $4.02 in pre-market trading after announcing it has finalized a cannabinoid development, licensing and commercialization agreement containing $300 million of R&D and milestone payments and long-term royalty streams.
- Southwestern Energy Company (NYSE:SWN) rose 5.1 percent to $4.76 in pre-market trading after surging 4.86 percent on Monday.
- HD Supply Holdings, Inc. (NASDAQ:HDS) shares rose 4.7 percent to $45.13 in pre-market trading following upbeat Q4 earnings.
- Fiat Chrysler Automobiles N.V. (NYSE:FCAU) shares rose 4.5 percent to $15.18 in pre-market trading.
- Veoneer, Inc. (NYSE:VNE) shares rose 4.3 percent to $24.86 in pre-market trading after falling 3.29 percent on Monday.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- AquaBounty Technologies, Inc. (NASDAQ:AQB) fell 19.3 percent to $2.26 in pre-market trading. AquaBounty priced its 3.35 million share common stock offering at $2.25 per share.
- resTORbio, Inc. (NASDAQ:TORC) fell 8.8 percent to $8.25 in pre-market trading after the company reported Q4 results and announced a $50 million common stock offering.
- Covenant Transportation Group, Inc. (NASDAQ:CVTI) fell 8.7 percent to $19.54 in pre-market trading on worse-than-expected Q1 guidance.
- DSW Inc. (NYSE:DSW) shares fell 7.3 percent to $23.50 in pre-market trading after reporting downbeat quarterly earnings.
- PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) fell 6.9 percent to $5.80 in pre-market trading after jumping 64.52 percent on Monday.
- PFSweb, Inc. (NASDAQ:PFSW) fell 6.5 percent to $5.95 in pre-market trading after reporting downbeat Q4 earnings.
- AzurRx BioPharma, Inc. (NASDAQ:AZRX) fell 6.1 percent to $2.01 in pre-market trading after rising 4.15 percent on Monday.
- Del Taco Restaurants, Inc. (NASDAQ:TACO) fell 5.8 percent to $9.98 in pre-market trading after the company reporter lower-than-expected Q4 EPS results. The company also issued FY19 EPS guidance below analyst estimates and FY19 sales on the low-end of analyst estimates.
- Yext, Inc. (NYSE:YEXT) shares fell 5.4 percent to $21.75 in pre-market trading. Yext priced its 6.1 million share offering of common stock at $21.50 per share.
- Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) fell 5.2 percent to $107.53 in pre-market trading.
- Yext Inc (NASDAQ:YEXT) shares fell 5.2 percent to $21.80 in pre-market trading. Yext priced its 6.1 million share offering of common stock at $21.50 per share.
- INSYS Therapeutics, Inc. (NASDAQ:INSY) fell 5.2 percent to $4.16 in pre-market trading after surging 5.80 percent on Monday.
- Nomad Foods Ltd (NYSE:NOMD) fell 4.9 percent to $20.40 in pre-market trading after reporting a 20 million share common stock offering.
- Aptinyx Inc. (NASDAQ:APTX) fell 4.8 percent to $4.00 in pre-market trading. Aptinyx is expected to release Q4 results on March 21.
- Healthequity Inc (NASDAQ:HQY) fell 4.7 percent to $79.00 in pre-market trading after the company issued FY20 EPS guidance below analyst estimates..
- Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) fell 4.6 percent to $12.50 in pre-market trading.
- Akebia Therapeutics Inc (NASDAQ:AKBA) fell 4.5 percent to $7.80 in pre-market trading following Q4 results.
- Uniti Group Inc. (NASDAQ:UNIT) fell 4.4 percent to $9.03 in pre-market trading. Uniti Group will host a conference call to discuss its Q4 financial results on March 20, 2019 at 4:15 PM ET.
- Moderna, Inc. (NASDAQ:MRNA) fell 4.3 percent to $21.22 in pre-market trading.
- The Southern Company (NYSE:SO) shares fell 4 percent to $49.75 in pre-market.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.